Using the K-M Plotter database, we found that OTUD7B upregulation reflected an unfavorable prognosis in terms of RFS probability in patients receiving pre-operative paclitaxel chemotherapy with unclassified (Figure 6A) and basal-like (Figure 6B) breast cancer. This evidence concerns the gene OTUD7B and breast carcinoma.